Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/18/2024
C Ray Thera Secures Over $100M to Advance Radiopharma Innovations
11/18/2024
IMPACT Thera Raises $34M in Series D++ Funding to Advance PARP Inhibit...
11/18/2024
Merck KGaA and Abbisko's Pimicotinib Shows Promise in Treating Rare Jo...
11/18/2024
CDE Issues the Guidelines for Application of Disease Registry-Based Re...
11/18/2024
Rona Therapeutics Unveils Promising Phase 1 Results for RNA-Based Chol...
11/18/2024
Biosion Announces Global License Deal with Aclaris on Two Potential FI...
11/18/2024
Novo Nordisk Launches Weight Loss Drug Wegovy in China
11/18/2024
Avenzo Inks $800 Million Deal for VelaVigo's Nectin-4/TROP2 Bispecific...
11/18/2024
FDA Grants BTD to Huahui Health's Libevitug (HH-003) for Chronic HDV I...
11/18/2024
LeadingTac Secures CNY100M+ in Series A Financing to Advance TPD-Based...
11/18/2024
ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
11/18/2024
New Report on China's Biopharma Revolution: A Decade of Progress and t...
11/18/2024
HCW Bio and WY Bio Enter License and Co-Development Deal
11/18/2024
China's Biopharma Boom: A Surge in Innovation and Drug Approvals
11/18/2024
CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
11/15/2024
NMPA Issues the Interim Rules on Designated Domestic Representatives f...
11/15/2024
Recent Executive Moves
11/14/2024
AstraZeneca Shifts to U.S. Expansion Amid Ongoing Challenges in China
11/14/2024
Lundbeck CEO Optimistic About Vyepti's Market Potential in China Follo...
11/14/2024
Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...
11/14/2024
NHC Holds Forum with Domestic and Foreign Pharma Cos on Compliance Iss...
11/14/2024
NHSA Holds Forum on Empowering Commercial Health Insurance with BMI Pl...
11/14/2024
CDE Seeks Public Comments on the Supplemental List of External Exper...
11/14/2024
BeiGene Rebrands as BeOne Medicines to Reflect Global Mission, Distanc...
11/14/2024
Zai Lab Aims to Raise $200M for Global Expansion and Innovative Drug D...
11/14/2024
Merck Enters into Global License Deal for LaNova's Anti-PD-1/VEGF BsAb...
11/14/2024
Europe's Pharma R&D Falling Behind as US Surges, China Rises
11/14/2024
Q3/2024 Performance of Leading MNCs in China: AZ Overtakes MSD as Nova...
11/14/2024
Passage to Asia: Early Access for Innovative Therapies (PharmExec)
11/14/2024
China on the Move: New Level of Opening up in Health Care Sector (NLR)
Page:
38
/
774
Total number of articles:
23207
:
[First]
[<<]
[36]
[37]
[38]
[39]
[40]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit